The Utilization and Safety of Umeclidinium and Umeclidinium/Vilanterol in UK Primary Care: A Retrospective Cohort Study

BACKGROUND: Umeclidinium bromide (UMEC) and umeclidinium/vilanterol (UMEC/VI) received European approval for maintenance treatment of patients with chronic obstructive pulmonary disease (COPD) in 2014. This study examined prescribing patterns, possible off-label prescribing, potential safety-related...

Descripción completa

Detalles Bibliográficos
Autores principales: Requena, Gema, Dedman, Daniel, Quint, Jennifer K, Ghosh, Rebecca E, Williams, Rachael, Pimenta, Jeanne M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956862/
https://www.ncbi.nlm.nih.gov/pubmed/33731992
http://dx.doi.org/10.2147/COPD.S291931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956862/
https://www.ncbi.nlm.nih.gov/pubmed/33731992
http://dx.doi.org/10.2147/COPD.S291931

Ejemplares similares